Advertisement
Screener

APTINYX INC. Patents: Applications Rejected

APTINYX INC. Patent Applications Rejected

11 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-12-02: Application 18000571; Invention SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL INFECTIONS USING THE SAME; Applicant Aptinyx Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
  • 2022-06-03: Application 17831544; Invention SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF; Applicant Aptinyx Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-05-07: Application 17314174; Invention SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF; Applicant Aptinyx Inc.; Status Abandoned -- Failure to Pay Issue Fee.
  • 2020-12-03: Application 17110481; Invention METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH NEURODEGENERATIVE DISEASE; Applicant Aptinyx Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2022-12-0218000571SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL INFECTIONS USING THE SAMEAptinyx Inc.Abandoned -- Incomplete Application (Pre-examination)US20230210851A1
M. Amin Khan
United States
2022-06-0317831544SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20230131402A1
M. Amin Khan
United States
RAO, DEEPAK R
2021-05-0717314174SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Pay Issue FeeUS20220098211A1
M. Amin Khan
United States
STOCKTON, LAURA LYNNE
2020-12-0317110481METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH NEURODEGENERATIVE DISEASEAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20210322393A1
Torsten M. Madsen
Ferenc Martenyi
United States
United States
MCMILLIAN, KARA RENITA
2020-11-1017094595METHODS OF TREATING FIBROMYALGIAAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20210308101A1
Torsten M. Madsen
United States
CHANDRAKUMAR, NIZAL S
2020-07-3016966176SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20210047324A1
M. Amin Khan
United States
AULAKH, CHARANJIT
2020-07-0216919438SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20210155632A1
John A. Lowe III
M. Amin Khan
United States
United States
SCHMITT, MICHAEL J
2018-11-2116197584SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAMEAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20190330209A1
M. Amin Khan
United States
DESAI, RITA J
2018-05-0215968976SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20180244680A1
John A. Lowe III
M. Amin Khan
United States
United States
SCHMITT, MICHAEL J
2018-03-2815938040SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Respond to an Office ActionUS20180215767A1
John A. Lowe III
M. Amin Khan
United States
United States
SCHMITT, MICHAEL J
2017-08-0815671409SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOFAptinyx Inc.Abandoned -- Failure to Pay Issue FeeUS20180179218A1
John A. Lowe III
M. Amin Khan
United States
United States
SCHMITT, MICHAEL J